Mr. Speaker, I was in the process of saying that the Canadian Medical Association Journal said that the first drug in relation to which it would put information on its website is a drug that last week the FDA issued a note on in terms of adverse drug reactions. It so happens that last week so did Health Canada. We acted the same week as the FDA in relation to that drug.
The point is that by whatever means it is important to get this information out to physicians and patients. Health Canada has accepted all the recommendations of the jury. We are committed to doing the job well.